Background and aim: Influenza diagnostics play a critical role informing in clinical
| INTRODUCTION
Globally, viral respiratory infections-including influenza-are a leading cause of morbidity and mortality. Early and accurate diagnosis of influenza can inform better treatment decisions, including reducing the inappropriate use of antibiotics.
1,2 Influenza diagnostics are not commonly used in the majority of low-income and middle-income countries (LMICs), and clinicians rely on signs as well as on a consideration of seasonal epidemics and locally circulating viruses, to inform case management and treatment decisions. However, as influenza may be difficult to differentiate from other acute febrile illnesses, the collection of an appropriate sample and an accurate laboratory diagnostic test is required to establish a definitive diagnosis. 3 While multiple options for influenza diagnostics exist, these tools vary considerably in accuracy, complexity, turnaround time, and other important performance characteristics. 4 In addition, the necessary performance requirements of the diagnostic will depend on the context of use, be it for public health surveillance or to inform patient care at a referral hospital. 5, 6 Recent evidence suggests that inappropriate or insensitive diagnostic assays may lead to the mismanagement of influenza cases. 7 Moreover, reliance on central laboratories poses a challenge not only to improving patient case management but also to controlling nascent outbreaks and generating influenza surveillance data, particularly in places with limited laboratory capacity. This challenge is particularly evident in LMICs where laboratories have limited capacity and influenza epidemiology is poorly understood. The cost, complexity, and turnaround times associated with these technologies often limit access outside of higher tier reference laboratories. 17, 18 In both clinical case management and public health surveillance, as influenza diagnostics move closer to the patient and to the point of care (POC), the end user group also shifts, spurring a change in product design and development needs. It is critical to identify key product attributes that promote usability, as more complex diagnostics move into peripheral health laboratories and clinics. In addition to performance evaluations, usability assessments are needed to understand training requirements, whether target end users can successfully use the test and whether new tests can be feasibly integrated into health system policies and practices. This requires an assessment of nextgeneration diagnostic tools in target use cases.
The Philippines represents an ideal setting for evaluation, given the potential need for new influenza diagnostic products within its growing health care market that includes both private and public segments. Also, it is located in an area of global importance for influenza. 
| Participant characteristics
Six laboratory managers participated in this study. Laboratory technicians, rather than primary care providers, were the designated intended users for the tests. In the participating study hospitals, all diagnostic tests are conducted in the laboratory and at not at the bedside, regardless of complexity. Laboratory technicians often conduct rapid tests, such as dengue rapid tests. Forty-six medical technicians (medtechs) participated in the evaluation of the influenza tests. Common responsibilities of medtechs include sample receipt, sample processing and testing, and specimen collection, including blood extraction, and releasing test results.
| Study design
This study used mixed methods to evaluate the usability and explore the feasibility of integrating near-patient influenza diagnostic tests into clinical case management. To explore the feasibility of integrating nearpatient influenza diagnostic tests into clinical case management, key decision-makers in the management of the laboratory at each hospital were recruited, to participate in an interview using a structured questionnaire.
The questionnaire was piloted with the study team at RITM and allowed for "other" responses, to fully capture the participants' responses. The questionnaire focused on current testing procedures, laboratory systems and infrastructure, and how new tests are integrated into the laboratory.
Convenience sampling was then used to recruit and enroll laboratory technicians to participate in the usability testing of the influenza diagnostics. Sampling was based on availability and willingness to participate and provide informed consent. To evaluate the usability of current influenza RITM not involved in the study, and revised based on their feedback through an iterative process. Participants used either a digital or paper-based version of the instructions. The paper-based version of the instructions was printed and provided to users prior to running the test. The digital instructions were provided on a laptop computer on the bench; the content was identical to the paper-based version, but only 1 step was shown at a time (arrows indicated where the user should click to move to the next step), and they included a built-in timer for timed steps. The manufacturer's IFU included in the test kit was used for the BD Veritor. A randomization procedure was used to assign laboratory technicians to 1 of the 3 study arms: (1) the prototype molecular test using digital instructions, (2) the prototype molecular test using paper instructions, or (3) the BD Veritor RIDT.
Medical technicians performed the RIDT or the molecular test protocol and were asked to speak aloud what they were doing and thinking. No real samples were used; participants used water in place of specimen. The molecular test was programmed to give a contrived result, and the RIDT gave an invalid result. This testing procedure is referred to as the first run. They returned 24 hours later to run the same test protocol, referred to as the second run. User interactions were observed by the research team and captured with audio and video recording. Observations were recorded on standardized data collection forms by the research team and entered into an ACCESS database. These data were tabulated and counted to evaluate usability considerations and user errors at each step of the procedure.
Participants were interviewed about their experience using a semistructured exit interview guide focused on form factor, workflow processes, IFU, and overall impressions. Data from the interviews with laboratory managers and exit interviews with laboratory technicians were transcribed, double-entered using ACCESS software, and coded based on themes related to usefulness, learnability, and user preferences. Data coded were reviewed by 2 members of the study team, categorized to develop ranked user preferences, and extracted to develop process maps.
The study protocol was reviewed and approved by the institutional ethical and scientific review committees at both PATH and RITM. Informed consent was obtained from all participants.
3 | RESULTS
| Feasibility of integrating near-patient influenza diagnostic tests into clinical case management
While participants in the study had experience performing rapid diag- To understand how near-patient influenza diagnostics could be integrated into the clinic flow, laboratory managers were asked to describe the current processes and practices for laboratory testing at the facilities.
Process maps ( Figure 3) were generated based on their responses, which showed clear differences between inpatient and outpatient processes.
Some differences were observed between private and public facilities.
Notably, in outpatient private facilities, a cashier is involved to receive payment for the test. The cashier then uses the receipt of payment along with the physician's request to initiate the procedure, whereas in public or government facilities, no payment is required up front.
Currently, only the laboratory at RITM conducts confirmatory testing for influenza. Laboratory managers and the pathologist or head of the clinical laboratory are responsible for being aware of new technologies and also for making recommendations to the hospital administration regarding which tests should be added. They generally make a presentation and offer justification, including information on the cost of the investment as well as the equipment and training requirements. 
| Usability of the representative influenza diagnostic platform technologies
Overall, all 46 medical technicians were able to perform the entire test procedure through to obtaining a result. The majority of user errors was self-corrected and did not prevent users from completing the testing procedure. The most frequently observed user errors for both the molecular and RDT platforms occurred during sample preparation.
Among the steps of the test procedure for both platforms, addition of external buffers to the test device was reported as the most difficult step. The RDT reader test took users about 7 minutes of "hands-on" time for the first run while the molecular test took users about 15 minutes, again not including waiting times for incubations. In the second run, users on both platforms completed the test about 2 minutes faster. After running the tests, users outlined their preferences with regard to test form factor, workflow, and the accompanying IFU.
| Form factor
Users appreciated kit components that were easy to handle, light, compact, and portable. Users noted that while the RDT reader was compact enough to be used at the patient bedside, bedside testing is not currently conducted at any of the participating hospitals. Although the molecular platform required additional hardware components, users familiar with PCR machines noted that the required equipment was much smaller than other molecular platform products. Users appreciated that all ancillary supplies needed to run both tests were readily available in their laboratories and easy to reorder.
| Workflow
The molecular platform required a lengthier and more complex workflow compared with the RIDT reader. However, users reported that the workflow was acceptable and suggested that once a technician was familiar with the test, it could be done quickly and with a shorter turnaround time compared with conventional PCR. This is in line with managers' notion of ease of performance as defined primarily by the amount of time needed for use and training. Users of the RIDT reader suggested that after repeat use, they would likely no longer need to refer to the instructions. As all users ran only 1 sample, some questioned how well the platforms would accommodate batch testing.
For both tests, a digital readout of the test result was preferred, as it provided a more definitive interpretation and increased confidence in the test result. A rapid turnaround time for results was considered a requirement for tests intended to inform patient care.
| Instructions for use
The availability of clear instructions with images and text was important, though preferences for digital or paper-based instructions were mixed.
Reported benefits of the digital IFU were the integrated timer and the fact that users did not need to move around paper instructions while handling test components. Drawbacks included a lack of familiarity with digital interfaces and the need to learn about a new test and a new IFU format at the same time. Users were clearly more familiar with paper instructions and required less intervention from the study team to help them move between steps. Users appreciated that both IFU relied on common words and short and direct sentences. Images reportedly helped users identify kit components and understand how they should be positioned. While all participating medtechs had the requisite skills required to run both test platforms, some challenges were reported. Sample preparation steps posed the greatest difficulty for end users, followed by the addition of external buffers. Thus, the value of new tests in Manila and elsewhere may be limited until global and national guidelines are changed to reflect the role these tools can play in both screening and case management, and until clinicians adhere to these evolving guidelines.
This evaluation had several key limitations. For one, this usability assessment did not include the use of actual specimens or specimen collection, which may impact usability and feasibility of adoption.
Additionally, these platforms may require new systems and processes to accommodate the use of a potentially infectious specimen collected at the POC or near the patient. Furthermore, the adoption and use of new diagnostic platforms is highly contextual, and the findings of this study may not be applicable to other contexts, particularly in peripheral settings where access to health services and well-trained laboratorians are more limited. While the results of this study suggest that these tests could become part of routine practices with minimal training requirements, the medical technicians working in both settings were skilled, with several years of experience. This may or may not be the case in more peripheral health care settings with lower skilled medical technicians. This study sample is not exhaustive of all settings where better influenza diagnostics are needed.
| CONCLUSION
Although influenza diagnostics were not currently in use by any of the participating hospitals apart from RITM, results of the study indicated that the potential for influenza tests to be used within other laboratories in the Philippines is high. Priority attributes of future influenza diagnostic products should satisfy criteria considered important by laboratory managers: improved sensitivity and specificity over current rapid tests, high volume of tests demanded by clinicians, and low cost of equipment.
The impact of any improved diagnostic will be determined by whether the test is used for screening, differential diagnosis, or to inform treatment decisions, which will, in turn, be mediated by both 
